A dominant activating RAC2 variant associated with immunodeficiency and pulmonary disease
Authors:
- 1 March 2020
- journal article
- letter
- Published by Elsevier in Clinical Immunology
- Vol. 212, 120-122
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Dominant activating RAC2 mutation with lymphopenia, immunodeficiency, and cytoskeletal defectsBlood, 2019
- A monoallelic activating mutation in RAC2 resulting in a combined immunodeficiencyJournal of Allergy and Clinical Immunology, 2019
- A comprehensive three-dimensional assay to assess neutrophil defense against bacteriaJournal of Immunological Methods, 2018
- Rac2 Functions in Both Neutrophils and Macrophages To Mediate Motility and Host Defense in Larval ZebrafishThe Journal of Immunology, 2016
- Deciphering the Molecular and Functional Basis of RHOGAP Family ProteinsJournal of Biological Chemistry, 2016
- Recent Advances in DOCK8 Immunodeficiency SyndromeJournal of Clinical Immunology, 2016
- RAC2 loss-of-function mutation in 2 siblings with characteristics of common variable immunodeficiencyJournal of Allergy and Clinical Immunology, 2015
- Rac GTPases play critical roles in early T-cell developmentBlood, 2009
- Human neutrophil immunodeficiency syndrome is associated with an inhibitory Rac2 mutationProceedings of the National Academy of Sciences, 2000
- Proteins regulating Ras and its relativesNature, 1993